Q72498 (Q72498_9HIV1) Human immunodeficiency virus 1
POL polyprotein UniProtKBInterProInteractive Modelling
1003 aa; Sequence (Fasta)
It is possible new templates exist for this target since these models were created.
Available Structures
24 Experimental Structures
Description | PDB ID | Oligo-state | Range | Ligands | ||
---|---|---|---|---|---|---|
Structural Basis for Inhibitor-Induced Aggregation of HIV-1 Integrase | homo-4-mer | 4×2SQ; | ||||
Assess | ||||||
HIV-1 IN core domain in complex with 6-fluoro-1,3-benzothiazol-2-amine | homo-2-mer | 1×FBB; | ||||
Assess | ||||||
HIV-1 IN core domain in complex with 4-(1H-pyrrol-1-yl)aniline | homo-2-mer | 1×GLC; 4×CD; 2×SO4; 2×SNU; | ||||
Assess | ||||||
HIV-1 IN core domain in complex with (1-methyl-5-phenyl-1H-pyrazol-4-yl)methanol | homo-2-mer | 4×CD; 1×BCK; 1×SO4; | ||||
Assess | ||||||
Fragment-based approach to the design of ligands targeting a novel site on HIV-1 integrase | homo-2-mer | 1×GLC; 2×SO4; 2×MPV; 4×CD; | ||||
Assess | ||||||
Structure of HIV-1 integrase core domain in complex with sucrose | homo-2-mer | 1×GLC; 2×SO4; 4×CD; | ||||
Assess | ||||||
Crystal structure of the HIV-1 integrase core domain to 1.4A | homo-2-mer | 3×SO4; | ||||
Assess | ||||||
HIV-1 IN core domain in complex with (3R)-3,4-dihydro-2H-chromen-3-ylmethanol | homo-2-mer | 4×CD; 2×CL; 4×SO4; 2×BCU; | ||||
Assess | ||||||
HIV-1 IN core domain in complex with [1-(4-fluorophenyl)-5-methyl-1H-pyrazol-4-yl]methanol | homo-2-mer | 4×CD; 2×CL; 4×SO4; 2×FMQ; | ||||
Assess | ||||||
HIV-1 IN core domain in complex with 1-benzothiophen-6-amine 1,1-dioxide | homo-2-mer | 1×GLC; 4×CD; 1×SO4; 1×MWP; | ||||
Assess | ||||||
Fragment-based approach to the design of ligands targeting a novel site on HIV-1 integrase | homo-2-mer | 4×CD; 2×CL; 2×BMC; 6×SO4; | ||||
Assess | ||||||
Fragments bound to HIV-1 integrase | homo-2-mer | 4×CD; 1×SO4; 3×0NX; | ||||
Assess | ||||||
HIV-1 integrase core domain in complex with 2,1,3-benzothiadiazol-4-amine | homo-2-mer | 1×GLC; 4×CD; 2×SO4; 2×BTE; | ||||
Assess | ||||||
HIV-1 IN core domain in complex with 2,3-dihydro-1,4-benzodioxin-5-ylmethanol | homo-2-mer | 4×CD; 1×CL; 2×SO4; 1×DBJ; | ||||
Assess | ||||||
HIV-1 IN core domain in complex with 6-fluoro-4H-1,3-benzodioxine-8-carboxylic acid | homo-2-mer | 4×CD; 1×SO4; 1×FBG; | ||||
Assess | ||||||
Fragment-based approach to the design of ligands targeting a novel site on HIV-1 integrase | homo-2-mer | 1×GLC; 2×BBY; 2×CL; 6×SO4; 4×CD; | ||||
Assess | ||||||
Fragment-based approach to the design of ligands targeting a novel site in HIV-1 integrase | homo-2-mer | 4×CD; 1×SO4; 3×BZX; | ||||
Assess | ||||||
HIV-1 IN core domain in complex with 5-methyl-3-phenyl-1,2-oxazole-4-carboxylic acid | homo-2-mer | 4×CD; 2×SO4; 1×MOK; | ||||
Assess | ||||||
HIV-1 IN core domain in complex with (5-METHYL-3-PHENYL-1,2-OXAZOL-4-YL)METHANOL | homo-2-mer | 4×CD; 1×SO4; 1×MPK; | ||||
Assess | ||||||
HIV-1 IN core domain in complex with N-METHYL-1-(4-METHYL-2-PHENYL-1,3-THIAZOL-5-YL)METHANAMINE | homo-2-mer | 4×CD; 2×CL; 6×SO4; 2×MMJ; | ||||
Assess | ||||||
Fragment-based approach to the design of ligands targeting a novel site on HIV-1 integrase | homo-2-mer | 4×CD; 2×CL; 3×SO4; 2×833; | ||||
Assess | ||||||
a novel 13-ring macrocyclic HIV-1 protease inhibitors involving the P1'-P2' ligands | homo-2-mer | 1×NA; 5×CL; 1×GR7; 1×GOL; 1×ACT; | ||||
Assess | ||||||
a hydroxymethyl functionality at the 4-position of the 2-phenyloxazole moiety of HIV-1 protease inh… | homo-2-mer | 1×G53; 2×NA; 4×CL; | ||||
Assess | ||||||
Crystal structure of HIV-1 Protease NL4-3 WT in complex with darunavir | homo-2-mer | 1×017; 1×SO4; | ||||
Assess |
8 SWISS-MODEL models
Template | Oligo-state | QMEANDisCo | Range | Ligands | Trg-Tpl Seq id (%) | |
---|---|---|---|---|---|---|
4zhr.1.A | monomer | 0.80 | 99.46 | |||
Assess | ||||||
6rwl.1.B | monomer | 0.74 | 1×ZN; | 75.35 | ||
Assess | ||||||
6rwl.1.A | monomer | 0.74 | 1×ZN; | 75.35 | ||
Assess | ||||||
5u1c.1.A | monomer | 0.73 | 95.86 | |||
Assess | ||||||
3kt2.1.A | monomer | 0.73 | 86.55 | |||
Assess | ||||||
7sep.1.B | monomer | 0.71 | 96.80 | |||
Assess | ||||||
5u1c.1.B | monomer | 0.70 | 95.86 | |||
Assess | ||||||
5dzm.6.A | monomer | 0.65 | 94.81 | |||
Assess |